MBX Biosciences Announces Pricing of Initial Public Offering

7 days ago

CARMEL, Ind., Sept. 12, 2024 ( GLOBE NEWSWIRE ) -- MBX Biosciences, Inc. ( Nasdaq: MBX ) ( "MBX Biosciences" ) , a clinical-stage biopharmaceutical company focused on the discovery and development of novel precision peptide therapies for the treatment of endocrine and metabolic disorders, today ...

Ticker	Sentiment	Impact
BR	Neutral	5 %